On the results front, AstraZeneca is among the heavyweight companies in the spotlight. However, the biggest share price moves ...

The FTSE 100 has closed in the red, slipping 0.11 per cent to 8,175.63. Pharma giant AstraZeneca was among London’s biggest ...

Cellectis is confident about the continued progress of its ongoing clinical trials in hematological malignancies and is ...

SAN ANTONIO -- Patients with overweight or obesity lost an average one-fifth of their body weight with the highest dose of ...

The "CC Chemokine Receptor Type 5 Market Report 2024" report has been added to ResearchAndMarkets.com's offering.The CC ...

Biopharma production efforts are set to receive a big boost in the U.K. thanks to a new budget rolled out by the Labour Party ...

The "Cancer Antibody Drug Conjugates Market Size, Drugs Approval, Price, Sales & Clinical Trials Insight 2030" report has been added to ResearchAndMarkets.com's offering. Antibody drug conjugates ...

(MENAFN- GlobeNewsWire - Nasdaq) Dublin, Oct. 31, 2024 (GLOBE NEWSWIRE ... The promising pipeline also includes AstraZeneca and Daiichi Sankyo's Datopotamab Deruxtecan, a TROP2-directed antibody drug ...

Speaking in Dublin, Ms Richardson ... her to the title “Dame”, marked her work to secure the partnership with AstraZeneca for the production and distribution of the Covid-19 vaccine developed ...

Distinct immune “signatures” in patients who develop adverse events while taking immunotherapy for cancer may help oncologists identify patients at risk and treat them early to prevent serious side ...

Researchers from Beaumont Hospital and RCSI University Health Sciences in Dublin, Ireland ... and receives honoraria from Exelixis, AstraZeneca, Replimune, Hepion Pharmaceuticals, Lantheus ...